JFJean-Luc Fellahi

Jean-Luc Fellahi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jean-Luc Fellahi has a total of 156 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Individualized mean arterial pressure during cardiac surgery The OPTIPAM Randomized Clinical Trial

    by Richard Descamps, Paul-Michel Mertes, Martin Charvin, Olivier Desebbe, Hélène Charbonneau, Jean-Luc Fellahi, Laure Cazenave, François Labaste, Diane Lena, Bertrand Rozec, et al.

    Background: Whether targeting an individualized mean arterial pressure (MAP) during cardiac surgery improves outcomes remains uncertain. The balance between improved perfusion and vasopressor-driven blood pressure augmentation is unclear. Methods: In this single-blind, multicenter randomized clinical trial conducted in 10 tertiary centers in France, adult patients undergoing elective cardiac surgery with cardiopulmonary bypass were assigned to either individualized MAP management (target within ±10% of preoperative baseline during surgery and for 24 h postoperatively) or standard management (target MAP ≥65 mm Hg). The primary outcome was a composite of all-cause death, acute kidney injury, or prespecified neurologic complications within 7 days. Safety outcomes included hemorrhagic complications and transfusion requirements. Results: A total of 172 patients were enrolled before the trial was stopped early by the data and safety monitoring board because of increased bleeding in the individualized group. Mean intraoperative MAP was higher with individualized management (80.6 vs 75.6 mm Hg; P<0.001), despite limited target adherence (33% of intraoperative time) and greater vasopressor use. The primary outcome occurred in 27 of 85 patients (32%) in the individualized group and 25 of 87 (29%) in the standard group (relative risk, 1.1; 95% CI, 0.7 to 1.8; P=0.76). Hemorrhagic complications occurred more frequently in the individualized group (18% vs 3%; P=0.003). Conclusions: In patients undergoing cardiac surgery, it was not possible to determine whether an individualized MAP strategy reduced major postoperative complications. More bleeding complications were observed in the individualized group. Future studies should further investigate this safety signal when evaluating individualized blood pressure targets.

  • Pro: we should fully utilise the preload reserve in high-risk patients undergoing noncardiac surgery

    by Jean-Luc Fellahi, Emmanuel Futier, Bernard Cholley, Matthias Jacquet-Lagreze

    In high-risk surgical patients undergoing noncardiac procedures, volume expansion through the titrated administration of small fluid challenges following anaesthesia induction does not lead to excessive cumulative fluid balance compared to standard care. This strategy may contribute to the prevention of haemodynamic instability and occult hypoperfusion, especially within critical vascular beds. In this context, the French guidelines recommend the prophylactic optimisation of stroke volume through titrated fluid administration as a physiologically justified and clinically appropriate practice that should be routinely adopted by anaesthesiologists in the operating room.


  • Open Access

    Prevention and Treatment of New-Onset Postoperative Atrial Fibrillation in the Acute Care Setting: A Narrative Review

    by Jean-Luc Fellahi, Marc-Olivier Fischer, Martin Ruste, Matthias Jacquet-Lagreze

    New-onset postoperative atrial fibrillation (POAF) is common after cardiac and major noncardiac surgery and significantly associated with short- and long-term adverse events. Multiple management strategies have been described but the lack of evidence from large randomized controlled trials and the lack of consensus regarding best practices has led to major variations in practice patterns. Considering on the one hand its serious adverse effects and complex drug interactions, and on the other hand discrepancies among recent international guidelines, the indications of amiodarone to both prevent and treat POAF should be reserved to patients at high risk of POAF only, or patients with hemodynamic instability and/or severely reduced left ventricular ejection fraction. Perioperative optimization of oral and intravenous cardio-selective beta-blockers to prevent POAF, and control heart rate when POAF occurs with a rapid ventricular response is the recommended first-line strategy, simultaneously with the treatment of associated factors. Given their efficient and safe profile, ultra-short-acting intravenous beta-blockers like esmolol or landiolol could be preferentially used in acute care patients. Besides waiting for the results of ongoing RCTs in cardiac and noncardiac surgery, the use of oral anticoagulation in patients with POAF should take into account the individualized thromboembolic/hemorrhagic risk ratio.


  • Open Access

    Prevention and Treatment of New-Onset Postoperative Atrial Fibrillation in the Acute Care Setting: A Narrative Review

    by Jean-Luc Fellahi, Marc-Olivier Fischer, Martin Ruste, Matthias Jacquet-Lagreze

    New-onset postoperative atrial fibrillation (POAF) is common after cardiac and major noncardiac surgery, and significantly associated with short- and long-term adverse events. Multiple management strategies have been described but the lack of evidence from large randomized controlled trials and the lack of consensus regarding best practices has led to major variations in practice patterns. Considering on the one hand its serious adverse effects and complex drug interactions, and on the other hand discrepancies among recent international guidelines, the indications of amiodarone to both prevent and treat POAF should be reserved to patients at high risk of POAF only, or patients with hemodynamic instability and/or severely reduced left ventricular ejection fraction. Perioperative optimization of oral and intravenous cardio-selective beta-blockers to prevent POAF, and control heart rate when POAF occurs with a rapid ventricular response is the recommended first-line strategy, simultaneously with the treatment of associated factors. Given their efficient and safety profile, ultra-short-acting intravenous beta-blockers like esmolol or landiolol could be preferentially used in acute care patients. Besides, and waiting for the results of ongoing RCTs in cardiac and noncardiac surgery, the use of oral anticoagulation in patients with POAF should take into account the individualized thromboembolic/hemorrhagic risk ratio.

  • High-Sensitivity Troponin I Release After Aortic Surgery: A Mechanistic Approach with Contrast-Enhanced Magnetic Resonance Imaging (the MITEC Study)

    by Jean-Luc Fellahi, Arnaud Ferraris, Pascal Chiari, Yvonne Varillon, Charles De Bourguignon, Nathan Mewton

  • Open Access

    Myocardial protection in cardiac surgery: a comprehensive review of current therapies and future cardioprotective strategies

    by Pascal Chiari, Jean-Luc Fellahi

    Cardiac surgery with cardiopulmonary bypass results in global myocardial ischemia–reperfusion injury, leading to significant postoperative morbidity and mortality. Although cardioplegia is the cornerstone of intraoperative cardioprotection, a number of additional strategies have been identified. The concept of preconditioning and postconditioning, despite its limited direct clinical application, provided an essential contribution to the understanding of myocardial injury and organ protection. Therefore, physicians can use different tools to limit perioperative myocardial injury. These include the choice of anesthetic agents, remote ischemic preconditioning, tight glycemic control, optimization of respiratory parameters during the aortic unclamping phase to limit reperfusion injury, appropriate choice of monitoring to optimize hemodynamic parameters and limit perioperative use of catecholamines, and early reintroduction of cardioprotective agents in the postoperative period. Appropriate management before, during, and after cardiopulmonary bypass will help to decrease myocardial damage. This review aimed to highlight the current advancements in cardioprotection and their potential applications during cardiac surgery.


  • The Surgical Critically Ill Patients: A Focus on Deresuscitation Strategy

    by Martin Ruste, Jean-Luc Fellahi, Matthias Jacquet-Lagrèze

  • Advantages and limitations of noninvasive devices for cardiac output monitoring: a literature review

    by Martin Ruste, Matthias Jacquet-Lagrèze, Jean-Luc Fellahi

    Purpose of review: Individualized hemodynamic optimization often requires cardiac output monitoring, mostly for goal-directed therapy in the operating room and fluid responsiveness assessment in the intensive care unit. Different technologies for noninvasive cardiac output determination have become available over the recent years. It is therefore crucial for care providers to be made aware of the advantages and limitations of those different devices for an appropriate use at the bedside. Recent findings: Nowadays, different noninvasive technologies exist, each with their advantages and limitations, but none are considered interchangeable with bolus thermodilution. Different clinical studies however, emphasize that the trending ability of such devices allows to guide decisions from care providers, and that their use may be associated with improved prognosis, especially in the operating room. Recent studies have also reported their potential use for hemodynamic optimization in specific populations. Summary: Noninvasive cardiac output monitoring may have a clinical impact on patient outcomes. Further studies are required to evaluate their clinical relevance, notably in the intensive care unit. Noninvasive monitoring opens up the possibility for hemodynamic optimization in specific or low-risk populations, the benefit of which remains to be assessed.


  • Fluids, vasopressors, and acute kidney injury after major abdominal surgery. Comment on Br J Anaesth 2022; 129: 317–26

    by Jean-Luc Fellahi, Rémi Schweizer, Martin Ruste, Matthias Jacquet-Lagreze

  • Refilling and preload dependence failed to predict cardiac index decrease during fluid removal with continuous renal replacement therapy

    by Matthias Jacquet-Lagrèze, Martin Ruste, William Fornier, Pierre-Louis Jacquemet, Remi Schweizer, Jean-Luc Fellahi

    Background: Fluid removal can reduce the burden of fluid overload after initial resuscitation. According to the Frank-Starling model, iatrogenic hypovolemia should induce a decrease in cardiac index. We hypothesized that inadequate refilling detected by haemoconcentration during fluid removal or an increase in cardiac index (CI) during passive leg raising (PLR) could predict CI decrease during mechanical fluid removal with continuous renal replacement therapy (CRRT). Methods: We conducted a single-centre prospective diagnostic accuracy study. The primary objective was to investigate the diagnostic performance of plasma protein concentration variations in detecting a CI decrease ≥ 12% during mechanical fluid removal. Secondary objective was to assess other predictive factors of CI change. The attending physician prescribed a fluid removal challenge consisting of a mechanical fluid removal challenge of 500 mL for one hour. Plasma protein concentration, haemoglobin level, PLR and transpulmonary thermodilution were done before and after the fluid removal challenge. Results: We included 69 adult patients between December 2016 and April 2020. Sixteen patients had a significant CI decrease (23% [95% CI 14–35]). Haemoconcentration and PLR before fluid removal challenge or CI trending failed to predict CI decrease. Conclusion: Haemoconcentration variables, preload dependence status and CI trending failed to predict CI decrease during fluid removal challenge.